N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production
N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of C-proteinase and for treating or preventing disorders related to unregulated collagen production
申请人:——
公开号:US20030191309A1
公开(公告)日:2003-10-09
The present invention relates to a novel class of organic molecules capable of inhibiting C-proteinase, and to their use to regulate, modulate and/or inhibit abnormal collagen formation as a therapeutic approach towards the treatment of fibrotic disorders.
N-SUBSTITUTED ARYLSULFONYLAMINO HYDROXAMIC ACIDS USEFUL AS INHIBITORS OF C-PROTEINASE AND FOR TREATING OR PREVENTING DISORDERS RELATED TO UNREGULATED COLLAGEN PRODUCTION
申请人:FIBROGEN, INC.
公开号:EP1154992A1
公开(公告)日:2001-11-21
EP1154992A4
申请人:——
公开号:EP1154992A4
公开(公告)日:2003-05-28
US6506936B1
申请人:——
公开号:US6506936B1
公开(公告)日:2003-01-14
[EN] N-SUBSTITUTED ARYLSULFONYLAMINO HYDROXAMIC ACIDS USEFUL AS INHIBITORS OF C-PROTEINASE AND FOR TREATING OR PREVENTING DISORDERS RELATED TO UNREGULATED COLLAGEN PRODUCTION<br/>[FR] ACIDES HYDROXAMIQUES ARYLSULFONYLAMINES N-SUBSTITUES, INHIBITEURS DE PROTEASE C, ET TRAITANT OU PREVENANT DES TROUBLES LIES A LA PRODUCTION NON REGULEE DE COLLAGENE
申请人:FIBROGEN INC
公开号:WO2000050390A1
公开(公告)日:2000-08-31
The present invention relates to a novel class of organic molecules capable of inhibiting C-proteinase, and to their use to regulate, modulate and/or inhibit abnormal collagen formation as a therapeutic approach towards the treatment of fibrotic disorders.